Type 1 Diabetes-PPT
                     Type 1 Diabetes
Presented by- DelveInsight Business Research

What is Type 1 Diabetes?
Diabetes is a chronic metabolic condition characterized by high or low blood glucose (or blood 
sugar) levels, leading to significant damage to the heart, blood vessels, eyes, kidneys, and nerves 
over time. The rationale behind developing diabetes incorporates two factors: insufficient insulin 
production (produced by the pancreas and reduced blood glucose) or unsatisfactory cell response 
to insulin action.
Clinically, diabetes is classified into three types, type 1 diabetes (TD-1), Type 1 Diabetes 
(TD2), and gestation diabetes. TD1 is the consequence of an autoimmune reaction that 
causes the pancreas to suppress insulin-producing β-cells and leads to a severe insulin 
deficiency.
TD2 is linked with a genetic factor, which is far more common and substantially 
correlates with obesity and unhealthy lifestyles. Insulin resistance (inadequate 
reaction of peripheral cells to insulin) and pancreatic β-cell dysfunction (impaired 
insulin secretion) are marked by Type 1 Diabetes, leading to relative insulin 
deficiency.
View– Type 1 Diabetes market insights
How Many Regions Are 
Covered?
● The US
● EU5 (Germany, France, Italy, Spain, 
and the United Kingdom)
● Japan
This segment of the report provides a brief 
competitive analysis of Type 1 Diabetes, 
to help understand the competition in the 
market. It gives a comparative understanding 
of the products based on types of wounds.
       Type 1 diabetes is an autoimmune disorder, it is the most common type of diabetes 
among children, and however, type 1 diabetes can occur at any age. The typical 
symptoms of type 1 diabetes include excessive thirst, blurred vision, dry mouth, upset 
stomach and vomiting, bedwetting, frequent urination, unexplained weight loss, 
fatigue, labored breathing, lack of energy, and constant hunger. In patients having 
extreme type 1 diabetes, the symptoms include fruity odor to the breath, belly pain, 
and rapid breathing.
       The cause of type 1 diabetes is unknown, however since it is an autoimmune disorder, 
wherein the body mistakenly attacks the insulin-producing (islet, or islets of 
Langerhans) cells in the pancreas, other causes include; genetics and exposure to 
viruses and other environmental factors.
       The diagnostic procedure to confirm type 1 diabetes includes Glycated hemoglobin 
(A1C) test (> 6.5 on two separate tests, Random blood sugar test (> 200 mg/dL, along 
with symptoms of diabetes), Fasting blood sugar test(> 126 mg/dL on two separate 
tests). If the patient is diagnosed with diabetes, the doctor checks the presence of 
autoantibodies using blood tests.
       Focusing on the chronic and severe nature of type 1 diabetes and type 2 diabetes, the 
treatment approach for them is quite comprehensive; regularization of glucose 
metabolism (continuous use of insulin) and control of risk factors are the key 
treatment targets for type 1 diabetes.
 
      Also, read– Type 1 Diabetes treatment market
What is the Type 1 Diabetes Market 
Report Scope?
● The report covers the descriptive overview of Type 1 Diabetes , explaining its causes, signs and 
symptoms, pathophysiology, diagnosis and currently available therapies
● Comprehensive insight has been provided into the Type 1 Diabetes epidemiology and treatment 
in the 7MM
● Additionally, an all-inclusive account of both the current and emerging therapies for Type 1 
Diabetes are provided, along with the assessment of new therapies, which will have an impact 
on the current treatment landscape
● A detailed review of Type 1 Diabetes market; historical and forecasted is included in the report, 
covering drug outreach in the 7MM
● The report provides an edge while developing business strategies, by understanding trends 
shaping and driving the global Type 1 Diabetes market
What are the Type 1 Diabetes Market
Report Highlights?
● In the coming years, Type 1 Diabetes market is set to change due to the rising awareness of the 
disease, and incremental healthcare spending across the world; which would expand the size of 
the market to enable the drug manufacturers to penetrate more into the market
● The companies and academics are working to assess challenges and seek opportunities that 
could influence Type 1 Diabetes R&D. The therapies under development are focused on novel 
approaches to treat/improve the disease condition       
● Major players are involved in developing therapies for Type 1 Diabetes . Launch of emerging 
therapies will significantly impact the Type 1 Diabetes market
● A better understanding of disease pathogenesis will also contribute to the development of novel 
therapeutics for Type 1 Diabetes
[email protected]
[email protected]
+91-9650213330
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
DFola tYiconu,  aHnda invfoeg rAapnhiycs  Q& uimeagsetsi obyn  or 
Freepik
Query?
Please keep this slide for attribution
Than
CREDITS: This presentation template was 
created by Slidesgo, including icons by 
Flaticon, and infographics & images by 
kFresepik !